We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Help improve GOV.UK Sign up to take part in user research (opens in a new tab)
Outcomes from the first meeting with the regulators of medicine who had met globally to discuss dementia.
Report on how community pharmacies can improve the prevention, early detection and management of blood pressure.
Outlines the level of payment due from members of the Pharmaceutical Price Regulation Scheme (PPRS) in 2018.
For manufacturers reporting adverse incidents with intraocular lenses under the vigilance system.
The Defence and Security Accelerator (DASA) is running a Market Exploration to explore research and technology development of relevance to the modelling of traumatic wounds and the monitoring of their progression.
Which product type to select when submitting a notification of intent to market e-cigarette and vape products in Northern Ireland.
Sets out the payment due from members of the voluntary scheme for branded medicines pricing and access in 2022.
A document for patients explaining how the highest risk patient groups eligible for new coronavirus treatments will be identified.
Information on the measures in the Health Service Medical Supplies (Costs) Bill.
Information for healthcare professionals, patients, and the public.
Guidance on applying for a Marketing Authorisation for Decentralised Manufacture, including eligibility, process, and requirements.
This guidance sets out the clinical requirements based on the consensus of what is ‘minimally acceptable’ performance in the opinion of the anaesthesia and intensive care medicine professionals and medical device regulators.
We use decades of experience in safe bioagent handling to support partners in research, development and testing of vaccines and therapeutics
Scientific advice queries on nanomedicines have increased in recent years, particularly on lipid nanoparticles.
Patient communication about a very low risk to patient safety in response to the field safety notice (FSN) issued by Diffuplast and MHRA.
Sets out the payment due from members of the voluntary scheme for branded medicines pricing and access in 2023.
How equipment for temperature screening is regulated, the limitations of temperature screening for detecting COVID-19 and advice on buying and using these products.
UK businesses can apply for a share of up to £8 million from the Industrial Strategy Challenge Fund for capital projects to improve medicines manufacturing.
Information for pharmaceutical wholesalers explaining the main changes the Windsor Framework introduces to the packaging for all medicines licensed in the UK, effective from 1 January 2025.
Data submission requirements for acute, community and private microbiology services submitting data on all LA/NHS chlamydia tests done in England.
Do not include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).